VTRS
Viatris Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
19.20
close · 2026-10-29
value
89
cheaper than peers89
quality
43
stronger fundamentals43
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
41 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 1.27× | 80 |
| forward P/E | 7.09× | 80 |
| EV to EBITDA | 7.22× | 80 |
| price to book | 1.56× | 76 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 12.6% | 64 |
| return on equity | -2.8% | 46 |
| revenue growth | 4.9% | 45 |
| debt to equity | 95.5% | 41 |
4 of 4 measures available
Facts
| market cap | $22B |
| free cash flow | $2.68B |
| employees | 30,000 |
| first trade | 1980-03-17 |
| next earnings | 2026-11-05 |
| fundamentals updated | 2026-08-10 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -3.00 | -0.53 | 0.05 | 1.71 |
| free cash flow | $1.85B | $1.94B | $2.33B | $2.51B |
| net income | -$3.51B | -$634.2M | $54.7M | $2.08B |
| revenue | $14.30B | $14.74B | $15.43B | $16.26B |
| unusual items | -$2.92B | -$700.2M | -$797.2M | -$40.8M |